Bal-Pharma Stock/Share Prices, Buy and Sell Bal-Pharma NSE Stocks

Market Snapshot

BSE Sensex: 40445.15 -0.82%
BSE 500: 15338.67 -0.90%
BSE 200: 4974.05 -0.90%
BSE 100: 11973.64 -0.90%
BSE Mid-Cap: 14667.37 -1.26%
BSE Small-Cap: 13339.35 -0.86%
BANKEX: 35751.43 -1.10%
BSE IT Sector: 15175.64 -0.13%
Nifty 50: 11921.5 -0.81%
Nifty 500: 9669.4 -0.90%
Nifty 200: 6129.9 -0.90%
Nifty 100: 12024.95 -0.84%
Nifty Midcap 100: 16732 -1.46%
Nifty Small 100: 5697 -0.95%
Nifty IT: 15289.6 -0.51%
Nifty PSU Bank: 2460.85 -4.39%

News:

HUDCO slumps over 10% in two s...
Maruti Suzuki skids after anno...
Omaxe Ltd leads losers in A gr...
Vodafone Idea slumps after cha...
Manaksia Coated Metals & Indus...

Bal Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

06 Dec 2019 | 04:14 PM

40.40

0.20 (0.50%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-48.27%

Return (1Y)

Underperformed Nifty 50 by 60.73%
More Volatile

3.05%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.15%
Inconsistent Performer

1/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

News & Announcements

Bal Pharma reports consolidated net loss of Rs 1.99 crore in the September 2019 quarter
19 days ago

Bal Pharma reports consolidated net loss of Rs 1.99 crore in the September 2019 quarter

19 - Nov - 2019 12:00 AM | 19 days ago

Net Loss of Bal Pharma reported to Rs 1.99 crore in the quarter ended September 2019 as against net loss of Rs 0.75 crore during the previous quarter ended September 2018. Sales declined 21.73% to Rs 44.99 crore in the quarter ended September 2019 as against Rs 57.48 crore during the previous quarter ended September 2018.
Particulars Quarter Ended
Sep. 2019 Sep. 2018 % Var.
Sales 44.99 57.48 -22
OPM % 4.07 7.19 -
PBDT -1.47 1.06 PL
PBT -2.83 -0.10 -2730
NP -1.99 -0.75 -165
Powered by Capital Market - Live News
Bal Pharma reports standalone net loss of Rs 1.58 crore in the September 2019 quarter
19 days ago

Bal Pharma reports standalone net loss of Rs 1.58 crore in the September 2019 quarter

19 - Nov - 2019 12:00 AM | 19 days ago

Net loss of Bal Pharma reported to Rs 1.58 crore in the quarter ended September 2019 as against net profit of Rs 0.46 crore during the previous quarter ended September 2018. Sales declined 23.36% to Rs 44.74 crore in the quarter ended September 2019 as against Rs 58.38 crore during the previous quarter ended September 2018.
Particulars Quarter Ended
Sep. 2019 Sep. 2018 % Var.
Sales 44.74 58.38 -23
OPM % 4.22 9.23 -
PBDT -1.02 2.31 PL
PBT -2.35 1.16 PL
NP -1.58 0.46 PL
Powered by Capital Market - Live News
Bal Pharma to declare Quarterly Result
40 days ago

Bal Pharma to declare Quarterly Result

29 - Oct - 2019 12:00 AM | 40 days ago

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2019.
Powered by Capital Market - Live News
Bal Pharma to discuss results
46 days ago

Bal Pharma to discuss results

23 - Oct - 2019 12:00 AM | 46 days ago

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2019.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Bal Pharma Ltd has opened at 42 i.e 4.48% above then yesterday's closing price of 40.2
Bal Pharma Ltd has the highest P/E ratio according to FY 201903 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2019	Sep. 2018	% Var.
Sales	44.99	57.48	-22
OPM %	4.07	7.19	-
PBDT	-1.47	1.06	PL
PBT	-2.83	-0.10	-2730
NP	-1.99	-0.75	-165

Particulars	Quarter Ended
	Sep. 2019	Sep. 2018	% Var.
Sales	44.74	58.38	-23
OPM %	4.22	9.23	-
PBDT	-1.02	2.31	PL
PBT	-2.35	1.16	PL
NP	-1.58	0.46	PL

General Notifications

My Notifications

Research Notifications

Bal Pharma Ltd NSE / BSE Pharmaceuticals, Small Cap

40.40 0.20 (0.50%)

News & Announcements

Price vs Volume

Stock Trivia

Bal Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

40.40

0.20 (0.50%)